Tech Company Financing Transactions

Trellis Bioscience Funding Round

Trellis Bioscience, operating out of Menlo Park, raised $10 million from Novartis BioVenture Fund, Easton Capital and Morgenthaler Ventures.

Transaction Overview

Company Name
Trellis Bioscience
Announced On
2/13/2007
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series B
Investors

Novartis BioVenture Fund (Lead Investor) (Markus Goebel)

Easton Capital (John Friedman)

Morgenthaler Ventures (James Broderick)

Pac-Link Bio

Sagamore Ventures

Proceeds Purpose
Proceeds from the financing will be used to develop Trellis' own product candidates, as well as its corporate partnering product candidates, and for general corporate purposes.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
845 Oak Grove Ave. 202
Menlo Park, CA 94025
USA
Phone
(650) 838-1400
Website
www.trellisbio.com
Email Address
Not Recorded
Overview
Trellis Bioscience, Inc. has developed a breakthrough technology platform for discovery and selection of very rare cells that produce ideal proteins such as antibodies, selected for specificity, selectivity, affinity, secretion rate and other desired characteristics.
Profile
Trellis Bioscience LinkedIn Company Profile
Social Media
Trellis Bioscience Company Twitter Account
Company News
Trellis Bioscience News
Facebook
Trellis Bioscience on Facebook
YouTube
Trellis Bioscience on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Stefan Ryser
  Stefan Ryser LinkedIn Profile  Stefan Ryser Twitter Account  Stefan Ryser News  Stefan Ryser on Facebook
Chief Marketing Officer
Anton Leighton
  Anton Leighton LinkedIn Profile  Anton Leighton Twitter Account  Anton Leighton News  Anton Leighton on Facebook
Chief Technical Officer
Stote Ellsworth
  Stote Ellsworth LinkedIn Profile  Stote Ellsworth Twitter Account  Stote Ellsworth News  Stote Ellsworth on Facebook
Founder
Lawrence Kauvar
  Lawrence Kauvar LinkedIn Profile  Lawrence Kauvar Twitter Account  Lawrence Kauvar News  Lawrence Kauvar on Facebook
VP - R & D
Mikhail Gishizky
  Mikhail Gishizky LinkedIn Profile  Mikhail Gishizky Twitter Account  Mikhail Gishizky News  Mikhail Gishizky on Facebook

 

 

Browse more venture capital transactions:

Prev: 2/13/2007: Cayenne Medical venture capital transaction
Next: 2/13/2007: iCrossing venture capital transaction

 

Share this article

 

About Our VC Transactions Data

We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.